TiumBio’s Post

At the Maui Derm NP+PA Fall conference, we spoke with Dr. Raj Chovatiya from Chicago Medical School at Rosalind Franklin U-Med & Science about the most promising recent therapy options for patients with #HidradenitisSuppurativa (HS). In his discussion, Dr. Chovatiya highlighted recent data on secukinumab, adalimumab, JAK inhibitors, and more. Check out the full interview segment here: https://lnkd.in/ekyrPthX

Complete chronic wound healing as a primary endpoint necessitates trials with large sample sizes and prolonged follow-up to achieve adequate statistical power. Listen to our Head of Clinical Studies, Kieron Day Ph.D., present a novel study metric - Percentage Area Reduction (PAR) - measured over a 4-week period, as a surrogate end point, and how the addition of the geko device significantly increased the PAR rate compared to compression therapy alone in the same cohort in our recently published study. https://lnkd.in/evDXtmyU

🙌 The BD FACSMelody™ provides you with some much-needed flexibility within your research. You will have the ability to separate out up to 4 populations into individual test tubes or 1 population into plates from 6 to 384 wells. Hear from Reiner Schulte about how these features help his core facility. To watch the full video, or to learn more about how the BD FACSMelody™ can support your research click here: 👉 https://lnkd.in/eygQdK6e   For Research Use Only. Not for use in diagnostic or therapeutic procedures. #CellSorting #FlowCytometry #BDBiosciences 

📰 Don’t Miss Our Recent Publication! 📰 🔊We are excited to share the release of our latest study: “Drug–Drug Interactions of Hydroxychloroquine and Chloroquine in Older Patients with COVID-19 during the First Pandemic Waves: The GeroCovid Observational Study,” authored by Caterina Trevisan. This research delves into the prevalence of drug interactions involving CQ and HCQ in older COVID-19 patients and examines their implications for hospitalization outcomes. 🔗https://whttps://brnw.ch/21wLLjS #COVID19 #Hydroxychloroquine #Chloroquine #DrugInteractions #GeroCovidStudy

Survodutide (GLP1RA/GCGRA) achieves primary endpoint in Ph2 clinical trial. -- Top-line result: ➡ 83% improvement in biopsy-proven MASH❗ https://lnkd.in/gEGRe5vH

Complete chronic wound healing as a primary endpoint necessitates trials with large sample sizes and prolonged follow-up to achieve adequate statistical power. Listen to our Head of Clinical Studies, Kieron Day Ph.D., present a novel study metric - Percentage Area Reduction (PAR) - measured over a 4-week period, as a surrogate end point, and how the addition of the geko device significantly increased the PAR rate compared to compression therapy alone in the same cohort in our recently published study. https://lnkd.in/evDXtmyU

💡 What are the current and future directions in treatment sequencing for anemic #myelofibrosis? In our latest #ClinicalTrialClub webinar, expert speakers, Jean-Jacques Kiladjian and Angela Fleischman, discussed the present clinical landscape and its challenges, how to optimize treatment sequencing, and explored ongoing clinical trials and key data. Don’t miss these fascinating presentations! https://lnkd.in/d-C269m4 https://lnkd.in/dx3yCBNq https://lnkd.in/dW-fS6P3 #MPN #MPNsm #MedicalEducation #CancerAwareness

Interested in fungal infections and how to diagnose them? This workshop is for you. Register now. See below. See you in December

Our outstanding team published a valuable research output entitled: The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial, August, 2024. Standard Mean Difference (SMD) is one of the most important “Effect sizes” to show the grade of treatment efficacy in RCTs. In addition, Intention-to-treat (ITT) analysis was performed in this RCT for sensitivity analysis.  DOI: 10.1038/s41598-024-69560-8 #randomizedcontrolledtrials #RCT #intentiontotreat #ITT #effectsize #sensitivityanalysis #chronicheartfailure #probiotic #synbiotic

#WAOJournal: Explore unique #asthma clinical clusters discovered through analysis of blood #transcriptome in this accessible study. https://lnkd.in/d3BKwgHJ #AsthmaResearch #MedicalDiscovery